Fort Lauderdale, FL, United States of America

Mutasem Rawas-Qalaji

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Mutasem Rawas-Qalaji

Introduction

Mutasem Rawas-Qalaji is a notable inventor based in Fort Lauderdale, Florida. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of sublingual epinephrine compositions. With a total of eight patents to his name, his work focuses on enhancing the bioavailability and therapeutic efficacy of epinephrine.

Latest Patents

One of his latest patents is titled "Sublingual epinephrine compositions including pH-modifying excipients and penetration enhancers and methods for use thereof." This invention provides sublingual epinephrine compositions that include epinephrine fine particles formulated with pH-modifying excipients and penetration enhancers. These compositions are designed to control the absorption of epinephrine at the site of delivery in the oral cavity. Additionally, the invention outlines methods for the therapeutic use of these sublingual compositions for treating conditions responsive to epinephrine and for increasing its sublingual bioavailability.

Another significant patent is the "Method for increasing plasma concentration of epinephrine in a subject having a condition responsive to epinephrine." This invention includes compositions featuring epinephrine nanoparticles and methods for their therapeutic use in treating conditions such as cardiac events or allergic reactions, particularly anaphylaxis. The epinephrine nanoparticles can be incorporated into orally-disintegrating and fast-disintegrating tablet formulations, significantly increasing the sublingual bioavailability of epinephrine and reducing the required dosage. Furthermore, the invention provides methods for fabricating stabilized epinephrine nanoparticles for use in these compositions.

Career Highlights

Throughout his career, Mutasem Rawas-Qalaji has worked with various institutions, including Nova Southeastern University. His innovative work has positioned him as a key figure in the development of advanced pharmaceutical solutions.

Collaborations

He has collaborated with notable individuals such as Ousama Rachid and Keith Simons, contributing to the advancement of his research and inventions.

Conclusion

Mutasem Rawas-Qalaji's contributions to the field of pharmaceuticals, particularly in the area of epinephrine formulations, highlight his innovative spirit and dedication to improving therapeutic outcomes. His patents reflect a commitment to enhancing drug delivery systems and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…